Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Male infertility

H W Baker1

  • 1Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women's Hospital, Australia.

Endocrinology and Metabolism Clinics of North America
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Male infertility affects many men, with only a quarter having specific causes. While some conditions are untreatable, others offer treatment options, and assisted reproductive technologies improve pregnancy chances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Treatment of Infected Wounds with Dichloramine-T with special Reference to its Advantages over the Carrol-Dakin Method.

Canadian Medical Association journal·2010
Same author

Frequency of disordered zona pellucida (ZP)-induced acrosome reaction in infertile men with normal semen analysis and normal spermatozoa-ZP binding.

Human reproduction (Oxford, England)·2001
Same author

The human acrosome reaction.

Asian journal of andrology·2001
Same author

Localisation of clusterin in normal human sperm by immunogold electron microscopy.

Pathology·2001
Same author

Feasibility of surveillance of changes in human fertility and semen quality.

Human reproduction (Oxford, England)·2001
Same author

Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception.

Contraception·2000
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Andrology
  • Urology

Background:

  • Male infertility is a significant health concern, affecting a substantial portion of couples seeking fertility treatment.
  • A considerable percentage of infertile men present with idiopathic reduced semen quality, lacking defined etiological factors or effective treatments.
  • Specific causes of male infertility, though less common, include conditions like primary seminiferous tubule failure and potentially treatable issues such as genital tract obstruction or hormonal imbalances.

Purpose of the Study:

  • To delineate the spectrum of male infertility causes, distinguishing between specific treatable conditions and idiopathic reduced semen quality.
  • To review the current therapeutic landscape for male infertility, including established treatments and emerging technologies.
  • To highlight the role of assisted reproductive technologies (ART) in managing male infertility, particularly in cases with severe sperm defects.

Related Experiment Videos

Main Methods:

  • Review of existing literature on male infertility diagnosis and management.
  • Categorization of male infertility causes based on etiological factors and treatability.
  • Analysis of the impact of assisted reproductive technologies, including intracytoplasmic sperm injection (ICSI), on pregnancy outcomes.

Main Results:

  • Approximately 25% of male infertility cases are attributable to specific, defined conditions.
  • Half of these specific cases involve untreatable primary seminiferous tubule failure, necessitating alternative family-building options.
  • The remaining half of specific cases present potentially treatable conditions, including obstruction, autoimmunity, and hormonal deficiencies.
  • The majority of men (75%) exhibit reduced semen quality without a clear underlying cause, and current treatments lack definitive efficacy in improving fertility for this group.
  • Assisted reproductive technologies, especially ICSI, have significantly improved pregnancy rates for couples facing male infertility, including those with severe sperm defects.

Conclusions:

  • Male infertility encompasses a range of conditions, from specific treatable causes to idiopathic reduced semen quality.
  • While some male infertility factors remain challenging to treat, advancements in ART offer viable solutions for achieving pregnancy.
  • Intracytoplasmic sperm injection represents a key technological advancement for overcoming severe male factor infertility.